-
Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides.
J Virol. 1998 Feb;72(2):986-93
PMID: 9444991
-
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1.
J Virol. 1993 Nov;67(11):6642-7
PMID: 7692082
-
Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.
J Virol. 2001 Nov;75(22):10892-905
PMID: 11602729
-
A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity.
J Virol. 1999 Mar;73(3):2469-80
PMID: 9971832
-
Identification of two sequences in the cytoplasmic tail of the human immunodeficiency virus type 1 envelope glycoprotein that inhibit cell surface expression.
J Virol. 2001 Jun;75(11):5263-76
PMID: 11333908
-
Simian immunodeficiency virus engrafted with human immunodeficiency virus type 1 (HIV-1)-specific epitopes: replication, neutralization, and survey of HIV-1-positive plasma.
J Virol. 2006 Mar;80(6):3030-41
PMID: 16501112
-
Differential functional phenotypes of two primary HIV-1 strains resulting from homologous point mutations in the LLP domains of the envelope gp41 intracytoplasmic domain.
Virology. 2007 Oct 10;367(1):102-16
PMID: 17582453
-
Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection.
J Virol. 2007 Jun;81(12):6187-96
PMID: 17409164
-
Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120.
J Virol. 2000 Sep;74(18):8358-67
PMID: 10954535
-
Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies.
Nat Med. 2005 Jun;11(6):615-22
PMID: 15880120
-
Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1.
J Virol. 2005 Jan;79(2):1252-61
PMID: 15613352
-
Virion envelope content, infectivity, and neutralization sensitivity of simian immunodeficiency virus.
J Virol. 2005 Oct;79(19):12455-63
PMID: 16160173
-
Antibody neutralization escape mediated by point mutations in the intracytoplasmic tail of human immunodeficiency virus type 1 gp41.
J Virol. 2005 Feb;79(4):2097-107
PMID: 15681412
-
Truncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodeficiency virus type 1 envelope protein.
J Virol. 2002 Mar;76(6):2683-91
PMID: 11861835
-
A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1.
AIDS Res Hum Retroviruses. 2001 Dec 10;17(18):1757-65
PMID: 11788027
-
In vivo and in vitro escape from neutralizing antibodies 2G12, 2F5, and 4E10.
J Virol. 2007 Aug;81(16):8793-808
PMID: 17567707
-
The cytoplasmic tail slows the folding of human immunodeficiency virus type 1 Env from a late prebundle configuration into the six-helix bundle.
J Virol. 2005 Jan;79(1):106-15
PMID: 15596806
-
Enfuvirtide resistance mutations: impact on human immunodeficiency virus envelope function, entry inhibitor sensitivity, and virus neutralization.
J Virol. 2005 Apr;79(8):4991-9
PMID: 15795284
-
Rational site-directed mutations of the LLP-1 and LLP-2 lentivirus lytic peptide domains in the intracytoplasmic tail of human immunodeficiency virus type 1 gp41 indicate common functions in cell-cell fusion but distinct roles in virion envelope incorporation.
J Virol. 2003 Mar;77(6):3634-46
PMID: 12610139
-
Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization.
J Virol. 1996 Mar;70(3):1651-67
PMID: 8627686
-
Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.
Biochemistry. 2003 Dec 9;42(48):14150-8
PMID: 14640682
-
Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies.
J Virol. 2004 Dec;78(23):13232-52
PMID: 15542675
-
The membrane-proximal external region of HIV-1 gp41: a vaccine target worth exploring.
AIDS. 2005 Nov 4;19(16):1725-37
PMID: 16227780
-
In vitro generation of HIV type 1 subtype C isolates resistant to enfuvirtide.
AIDS Res Hum Retroviruses. 2005 Sep;21(9):776-83
PMID: 16218801
-
Multiple domains of the SIV Env protein determine virus replication efficiency and neutralization sensitivity.
Virology. 2005 Feb 5;332(1):89-101
PMID: 15661143
-
Structural basis of enhanced binding of extended and helically constrained peptide epitopes of the broadly neutralizing HIV-1 antibody 4E10.
J Mol Biol. 2007 Feb 2;365(5):1533-44
PMID: 17125793
-
HIV-1 mutants escaping neutralization by the human antibodies 2F5, 2G12, and 4E10: in vitro experiments versus clinical studies.
AIDS. 2005 Nov 18;19(17):1957-66
PMID: 16260901
-
Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail.
J Virol. 2005 Oct;79(19):12231-41
PMID: 16160149
-
An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10.
J Virol. 2007 Apr;81(8):4033-43
PMID: 17287272
-
Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope.
J Virol. 2004 Oct;78(19):10724-37
PMID: 15367639
-
Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein.
J Virol. 1993 May;67(5):2747-55
PMID: 8474172
-
Dynamics of HIV-1 recombination in its natural target cells.
Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4204-9
PMID: 15010526
-
Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41.
Immunity. 2005 Feb;22(2):163-73
PMID: 15723805
-
Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions.
J Virol. 2003 May;77(10):5678-84
PMID: 12719560
-
Cytosolic domain of the human immunodeficiency virus envelope glycoproteins binds to calmodulin and inhibits calmodulin-regulated proteins.
J Biol Chem. 1993 Oct 25;268(30):22895-9
PMID: 8226798
-
Insensitivity of paediatric HIV-1 subtype C viruses to broadly neutralising monoclonal antibodies raised against subtype B.
PLoS Med. 2006 Jul;3(7):e255
PMID: 16834457
-
Genotypic and phenotypic characterization of viral isolates from HIV-1 subtype C-infected children with slow and rapid disease progression.
AIDS Res Hum Retroviruses. 2006 May;22(5):458-65
PMID: 16706624